| Primary |
| Glaucoma |
57.8% |
| Intraocular Pressure Increased |
17.1% |
| Open Angle Glaucoma |
5.9% |
| Ocular Hypertension |
3.7% |
| Atrial Fibrillation |
2.1% |
| Parkinson's Disease |
1.6% |
| Postoperative Care |
1.6% |
| Angle Closure Glaucoma |
1.1% |
| Cardiac Disorder |
1.1% |
| Cardiac Failure |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Macular Degeneration |
1.1% |
| Normal Tension Glaucoma |
1.1% |
| Alcoholic |
0.5% |
| Asthma |
0.5% |
| Blood Pressure Increased |
0.5% |
| Cataract |
0.5% |
| Cataract Congenital |
0.5% |
| Eye Disorder |
0.5% |
| Intraocular Pressure Test |
0.5% |
|
| Visual Impairment |
15.1% |
| Corneal Disorder |
5.8% |
| Deafness |
5.8% |
| Tremor |
5.8% |
| Visual Acuity Reduced |
5.8% |
| Vomiting |
5.8% |
| Deafness Transitory |
4.7% |
| Dyspnoea |
4.7% |
| Hypertension |
4.7% |
| Nausea |
4.7% |
| Vision Blurred |
4.7% |
| Vocal Cord Disorder |
4.7% |
| Condition Aggravated |
3.5% |
| Epistaxis |
3.5% |
| Limb Injury |
3.5% |
| Optic Nerve Disorder |
3.5% |
| Pain In Extremity |
3.5% |
| Palpitations |
3.5% |
| Pharyngitis |
3.5% |
| Sinusitis |
3.5% |
|
| Secondary |
| Glaucoma |
41.1% |
| Hypertension |
6.3% |
| Spinal Pain |
5.9% |
| Cerebral Infarction |
4.2% |
| Gastritis |
4.2% |
| Intraocular Pressure Increased |
4.1% |
| Drug Use For Unknown Indication |
3.9% |
| Product Used For Unknown Indication |
3.3% |
| Cardiac Failure Chronic |
3.2% |
| Lumbar Spinal Stenosis |
3.2% |
| Eye Disorder |
2.5% |
| Ocular Hypertension |
2.5% |
| Myopia |
2.4% |
| Angle Closure Glaucoma |
2.1% |
| Cardiac Failure |
2.1% |
| Prophylaxis |
2.1% |
| Asthma |
2.0% |
| Energy Increased |
1.8% |
| Anxiety |
1.6% |
| Open Angle Glaucoma |
1.6% |
|
| Sudden Cardiac Death |
9.4% |
| Vision Blurred |
9.4% |
| Dysplasia |
7.1% |
| Intraocular Pressure Increased |
7.1% |
| Visual Acuity Reduced |
7.1% |
| Myalgia |
5.9% |
| Conjunctivitis Allergic |
4.7% |
| Epistaxis |
4.7% |
| Lower Respiratory Tract Infection |
4.7% |
| Medication Error |
4.7% |
| Alopecia |
3.5% |
| Corneal Disorder |
3.5% |
| Drug Hypersensitivity |
3.5% |
| Gamma-glutamyltransferase Increased |
3.5% |
| Hyponatraemia |
3.5% |
| Prostate Cancer |
3.5% |
| Scar |
3.5% |
| Skin Hyperpigmentation |
3.5% |
| Visual Field Defect |
3.5% |
| Visual Impairment |
3.5% |
|
| Concomitant |
| Glaucoma |
27.6% |
| Product Used For Unknown Indication |
20.8% |
| Drug Use For Unknown Indication |
10.7% |
| Hypertension |
7.4% |
| Prophylaxis |
4.8% |
| Cardiac Failure |
3.5% |
| Asthma |
2.5% |
| Atrial Fibrillation |
2.3% |
| Diabetes Mellitus |
2.2% |
| Behcet's Syndrome |
2.0% |
| Depression |
2.0% |
| Rheumatoid Arthritis |
1.9% |
| Osteoporosis |
1.8% |
| Pain |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Open Angle Glaucoma |
1.6% |
| Cardiac Disorder |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Hormone Replacement Therapy |
1.3% |
| Intraocular Pressure Increased |
1.3% |
|
| Intraocular Pressure Increased |
13.7% |
| Visual Acuity Reduced |
13.3% |
| Glaucoma |
6.5% |
| Vision Blurred |
6.5% |
| Endophthalmitis |
4.6% |
| Vomiting |
4.6% |
| Fall |
4.2% |
| Fatigue |
4.2% |
| Ocular Hyperaemia |
4.2% |
| Dyspnoea |
3.8% |
| Rash |
3.8% |
| Urinary Tract Infection |
3.8% |
| Cataract |
3.4% |
| Death |
3.4% |
| Eye Irritation |
3.4% |
| Myocardial Infarction |
3.4% |
| Pain |
3.4% |
| Pain In Extremity |
3.4% |
| Renal Failure Acute |
3.4% |
| Breast Cancer Female |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
88.9% |
| Infantile Spasms |
11.1% |
|
| Intraocular Pressure Increased |
50.0% |
| Off Label Use |
50.0% |
|
